Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Name: Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

This statement provides guidance to clinical trial applicants about the investigational use of marketed drugs within clinical trials in Canada.